Mikhael, J. Richter, J. Vij, R. Cole, C. Zonder, J. Kaufman, J.L. Bensinger, W. Dimopoulos, M. Lendvai, N. Hari, P. Ocio, E.M. Gasparetto, C. Kumar, S. Oprea, C. Chiron, M. Brillac, C. Charpentier, E. San-Miguel, J. Martin, T., A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma, Leukemia Research, (34), 3298-3309, 2020, Springer Nature BV, 0145-2126